Suppliers / NCPC Hebei Huamin Pharmaceutical

NCPC Hebei Huamin Pharmaceutical

China 5 duplicate records merged Updated 9 July 2026

NCPC Hebei Huamin Pharmaceutical is an API and finished-dose manufacturer based in China. It holds 2 valid CEPs across a filed portfolio of 2 molecules. Its filings concentrate with NAFDAC (NG), MINSA (CR) and UZPHARM (UZ). Its GMP standing is certified by ANVISA (Brazil), UZPHARM (UZ) and EMA, among 5 authorities.

0
active US DMFs
2
valid CEPs
3
registered plants
20
filings across 5 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
SHIJIAZHUANG, China Not on file
SHIJIAZHUANG, China Not on file
Hebei Province, Nigeria Not on file

What they file, and where

Molecule Regulators Docs
Cefotaxime EDQM 1
Cefuroxime Sodium Sterile EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 8 1
MINSA (CR) 6 None
UZPHARM (UZ) 3 1
JFDA (JO) 2 None
ARCSA (EC) 1 None
ANVISA (Brazil) None 1
EMA None 1
MHRA (UK) None 1

Comparing suppliers?

Choose your molecules and target markets. NCPC Hebei Huamin Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates